Position in TRDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,963
-$197,856 QoQ
Shares Held
2,169
-87.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. TRDA ranks #300 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,963 | 2,169 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $213,819 | 16,943 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $172,929 | 16,822 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $185,286 | 31,946 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,333,986 | 496,129 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,207,890 | 1,239,811 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $24,204,546 | 1,399,916 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,861,097 | 1,743,498 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,065,600 | 1,829,165 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,379,440 | 167,921 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,081,042 | 535,523 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,197,432 | 582,116 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,810,526 | 581,937 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,705,416 | 531,408 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $6,812,876 | 503,911 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,941,574 | 503,907 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $11,508,979 | 944,908 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,233,095 | 876,794 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,892,896 | 285,800 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||